Podtschaske, B., & Friesdorf, W. (2012). Sicherheit fördern durch interprofessionelle Kooperation. mt -Medizintechnik. Organ des Fachverbandes Biomedizinische Technik e.V. (fbmt), des Bundesverbands der Sachverständigen für Medizinprodukte BSM sowie der VDI-Gesellschaft Technologies of Life Sciences, Fachbereich Medizintechnik., 132(4), 143–145. Abgerufen von https://www.mt-medizintechnik.de/zeitschrift-mt-medizintechnik/
Lübben, R., & Fidler, M. (2011). Poster: on the capacity delay error tradeoff of source coding. SIGMETRICS Perform. Eval. Rev., 39, 72–72. http://doi.org/10.1145/2034832.2034856 (Original work published 2026)
Leprévost, F., Pohst, M., & Uzunkol, O. (2011). On the Computation of Class Polynomials with "Thetanullwerte" and Its Applications to the Unit Group Computation. Experimental Mathematics, 20, 271–281. http://doi.org/10.1080/10586458.2011.565234 (Original work published 2026)
Brandenburg, M., & Seuring, S. (2011). Impacts of supply chain management on company value: benchmarking companies from the fast moving consumer goods industry. Logistics Research, 3(4), 233–248,. http://doi.org/10.1007/s12159-011-0056-7
Abstract
The research question addressed is to which extent supply chain management (SCM) creates value from cost and working capital. The paper provides an empirical evaluation including insights on important criteria for value creation. In a secondary data analysis, 10 leading fast moving consumer goods (FMCG) companies are benchmarked regarding the value created from cost of goods sold (COGS) and working capital within the time horizon 2003–2008. The study applies benchmarking methodology and a discounted cash flow (DCF) based model for quantifying value contributions. It is shown that SCM is realized in a value-adding way with different emphasis on COGS or working capital. Monetarily working capital components (trade payables, trade receivables) have a high relevance for value creation. Continuous improvements and long lasting developments of value drivers are more appropriate for value creation than alternating improvements and deteriorations. Timing aspects of value driver developments have to be considered for value creation. The value of the paper stems from empirical comparison of value created by working capital and COGS and from evidence of important criteria for value creation. Further analysis based on cost components as well as benchmarking with different or extended content, such as fixed asset performance or cross-industry benchmarking, leave room for future research.
Bott, O., Dresing, K., Wagner, M., Raab, B.-W., & Teistler, M. (2011). Informatics in Radiology: Use of a C-Arm Fluoroscopy Simulator to Support Training in Intraoperative Radiography. RadioGraphics, 31, E65-E75. http://doi.org/10.1148/rg.313105125
Barney, S., Khurum, M., Petersen, K., Unterkalmsteiner, M., & Jabangwe, R. (2011). Improving students with rubric-based self-assessment and oral feedback. IEEE transactions on Education, 55, 319–325.
Imhoff, J. F., Labes, A., & Wiese, J. (2011). Bio-mining the microbial treasures of the ocean: New natural products. Biotechnology Advances, 29, 468–482. Abgerufen von http://oceanrep.geomar.de/12044/
Abstract
The biological resources of the oceans have been exploited since ancient human history, mainly by catching fish and harvesting algae. Research on natural products with special emphasis on marine animals and also algae during the last decades of the 20th century has revealed the importance of marine organisms as producers of substances useful for the treatment of human diseases. Though a large number of bioactive substances have been identified, some many years ago, only recently the first drugs from the oceans were approved. Quite astonishingly, the immense diversity of microbes in the marine environments and their almost untouched capacity to produce natural products and therefore the importance of microbes for marine biotechnology was realized on a broad basis by the scientific communities only recently. This has strengthened worldwide research activities dealing with the exploration of marine microorganisms for biotechnological applications, which comprise the production of bioactive compounds for pharmaceutical use, as well as the development of other valuable products, such as enzymes, nutraceuticals and cosmetics. While the focus in these fields was mainly on marine bacteria, also marine fungi now receive growing attention. Although culture-dependent studies continue to provide interesting new chemical structures with biological activities at a high rate and represent highly promising approaches for the search of new drugs, exploration and use of genomic and metagenomic resources are considered to further increase this potential. Many efforts are made for the sustainable exploration of marine microbial resources. Large culture collections specifically of marine bacteria and marine fungi are available. Compound libraries of marine natural products, even of highly purified substances, were established. The expectations into the commercial exploitation of marine microbial resources has given rise to numerous institutions worldwide, basic research facilities as well as companies. In Europe, recent activities have initiated a dynamic development in marine biotechnology, though concentrated efforts on marine natural product research are rare. One of these activities is represented by the Kieler Wirkstoff-Zentrum KiWiZ, which was founded in 2005 in Kiel (Germany).
Pornak, S. C., Meyer, T., & Raspe, H. (2011). Priorisierung in der Medizin – Verlauf und Ergebnisse der dänischen Priorisierungsdebatte. Das Gesundheitswesen, 73, 680–687.